A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer

Alberto A. Chiappori, T. Kolevska, D. R. Spigel, S. Hager, M. Rarick, S. Gadgeel, N. Blais, J. Von pawel, L. Hart, M. Reck, E. Bassett, B. Burington, J. H. Schiller

Research output: Contribution to journalArticlepeer-review

94 Scopus citations

Fingerprint

Dive into the research topics of 'A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences